2 most recent filings and news items mentioning MTNB. Updated every 60 seconds.
M&AJul 13, 2026Neutral
Matinas BioPharma entered into a definitive business combination agreement with GH Power Inc. dated July 10, 2026. This strategic move aims to expand Matinas' asset portfolio in the pharmaceutical sector.
View filing at SEC.gov →
RegulatoryJun 26, 2026Neutral
Matinas BioPharma received notice of non-compliance with NYSE American listing standards due to falling below stockholders' equity requirements. The exchange accepted the company's remediation plan, granting a compliance period through October 2027.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.